EPA Issues Draft Revisions to its Risk Determination for N-Methylpyrrolidone (NMP) under the Toxic Substance Control Act
On July 1, 2022, EPA published a draft revision to its risk determination for n-methylpyrrolidone, also referred to as “NMP.” Previously, in 2020, EPA published a risk evaluation for NMP, finalizing determinations of unreasonable risk for specific conditions of use based on risks to the environment, workers, and occupational non-users.
As a result of recent policy changes, EPA is replacing its condition of use-specific unreasonable risk determinations with a determination of unreasonable risk for NMP as a whole chemical substance driven by certain condition of uses. Also, as part of the revision, EPA is removing the assumption of personal protective equipment use by workers which means that 29 out of the 37 conditions of use that drive the unreasonable risk determination based only on risks to the environment are now also being proposed to drive unreasonable risk based on health risks to workers.
Comments are due on August 1, 2022.
Advocacy contact: Send an email to Tabby Zeb at email@example.com or call 202-798-7405.